31 related articles for article (PubMed ID: 1772965)
21. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures.
Rabinovitch A; Pukel C; Baquerizo H
Endocrinology; 1988 Jun; 122(6):2393-8. PubMed ID: 2453340
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
23. Repetitive exposure of pancreatic islets to interleukin-1 beta. An in vitro model of pre-diabetes?
Helqvist S; Zumsteg UW; Spinas GA; Palmer JP; Mandrup-Poulsen T; Egeberg J; Nerup J
Autoimmunity; 1991; 10(4):311-8. PubMed ID: 1772965
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells.
Sandler S; Eizirik DL; Svensson C; Strandell E; Welsh M; Welsh N
Autoimmunity; 1991; 10(3):241-53. PubMed ID: 1836745
[No Abstract] [Full Text] [Related]
25. Innate immune priming of insulin secretion.
Dalmas E
Curr Opin Immunol; 2019 Feb; 56():44-49. PubMed ID: 30342375
[TBL] [Abstract][Full Text] [Related]
26. Application of genomics and proteomics in Type 1 diabetes pathogenesis research.
Sparre T; Bergholdt R; Nerup J; Pociot F
Expert Rev Mol Diagn; 2003 Nov; 3(6):743-57. PubMed ID: 14628902
[TBL] [Abstract][Full Text] [Related]
27. Roles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility.
Pullen TJ; Rutter GA
Front Genet; 2014; 5():193. PubMed ID: 25071823
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]